~~<i id='E5DEE6B4FF'><strike id='E5DEE6B4FF'><tt id='E5DEE6B4FF'><pre id='E5DEE6B4FF'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

entertainment

author：Wikipedia 2025-09-30 00:34:11 - browse：66

Monica Bertagnolli -- health policy coverage from STAT — NIH Director Monica Bertagnolli Kevin Dietsch/Getty Images

WASHINGTON — President Biden has promised to require fair prices from drugmakers that use federally funded research — and now, in a major recent move, said he’ll trigger government “march-in” on patents for drugs that run afoul of that goal.

“It’s a simple principle. You shouldn’t pay the highest price in the world for drugs that your tax dollars have already helped create,” Biden said last month as he touted the move at the National Institutes of Health.

But the new NIH director, locked in the center of this debate, isn’t taking any big steps yet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： R1 RCM gets $5.8 billion buyout offer from private equity firm

focus

hotspot

leisure time

explore

MollyFerguson/STATThisweek,anencouragingturnaroundforOcularTherapeutix,achatwithAlnylam’sCEOdefendin

WSS

The untold story of TV’s first prescription drug ad

STAT readers on older presidents, polypills, Medicare, and more

A new nitrogen execution bill also undermines medical licensing

Microsoft's Peter Lee: Generative AI could help doctors be more human

Ancient Greek ideas underpin modern concepts of pregnancy

NIH study of ME/CFS points to clear biological hallmarks

focus

entertainment

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

A new nitrogen execution bill also undermines medical licensing

Cancer drug shortages should be causing more outrage

Longer MASH drug regimen improved liver, Akero study finds

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Why Talkspace is targeting Medicare, a tricky market

Wildfire smoke exposes gaps in outdoor worker protections

Ed Silverman on new gene therapies, biosimilars, coffee, and more

After affirmative action ruling, medical educators look to 'holistic review'

New documents shed light on MD Anderson Cancer Institute feud

hotspot

Medicare drug price negotiation hearing pits pharma v Biden admin

State of the Union pitch: Bigger Medicare drug price negotiations

Ancient Greek ideas underpin modern concepts of pregnancy

New documents shed light on MD Anderson Cancer Institute feud

NIH study of ME/CFS points to clear biological hallmarks

The public health thinking behind the CDC’s new Covid guidance

hotspot

hotspot

leisure time

explore